FOXO4-DRI 18 mg

$199.00

FOXO4-DRI 18 mg is a research-focused listing from Skye Peptides. Review current product specifications, available documentation, and handling information. For lawful laboratory research and development only; not for human or veterinary use. Visit Skye Peptides.

FOXO4-DRI 18 mg – Short Product Description

FOXO4-DRI 18 mg is a synthetic peptide developed for scientific research into cellular senescence, FOXO4 signaling, and mechanisms involved in aging-related cellular processes. The peptide has attracted research interest because of its proposed interaction with the FOXO4-p53 pathway, which is involved in cellular stress responses and the regulation of senescent cells. Researchers study these mechanisms to better understand cell survival and biological aging. FOXO4-DRI remains experimental, and its safety and effectiveness in humans have not been established. Product identity, purity, and specifications should be verified through appropriate analytical documentation. This product is intended for research purposes and is not an established anti-aging treatment.